Loading…

Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience

Chemo-refractory NHL has a very poor outcome; the addiction of RIT to salvage regiment pre ASCT had recently demonstrated promising results.We performed a retrospective sequential study to determine the feasibility of standard Zevalin with BEAM in high-risk relapse/refractory NHL . A matched cohort...

Full description

Saved in:
Bibliographic Details
Published in:Annals of hematology 2018-09, Vol.97 (9), p.1619-1626
Main Authors: Ciochetto, Chiara, Botto, Barbara, Passera, Roberto, Bellò, Marilena, Benevolo, Giulia, Boccomini, Carola, Castellino, Alessia, Chiappella, Annalisa, Freilone, Roberto, Nicolosi, Maura, Orsucci, Lorella, Pecoraro, Clara, Pregno, Patrizia, Bisi, Gianni, Vitolo, Umberto
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chemo-refractory NHL has a very poor outcome; the addiction of RIT to salvage regiment pre ASCT had recently demonstrated promising results.We performed a retrospective sequential study to determine the feasibility of standard Zevalin with BEAM in high-risk relapse/refractory NHL . A matched cohort analysis with a group treated with standard BEAM without Zevalin was performed as secondary endpoint. Between October 2006 and January 2013, 37 NHL patients at high risk for progression or early (
ISSN:0939-5555
1432-0584
DOI:10.1007/s00277-018-3328-3